Navigation Links
Therapeutic Genes Transferred By Viral Vector Through T Cell Masking

Dr. Richard Vile, Mayo Clinic Molecular Immunologist and his team has found a new virus based gene therapy delivery system for the treatment of cancer, inflammation and autoimmune diseases. The new delivery system acts as a “T // cell Therapeutic hitchhiker”, by which the Therapeutic virus containing the required genes are transferred into the T cells in the immune system, as the T cells are the immune cells they get attracted towards the cancer cell or inflammatory cells by which it reaches the target cells with the T cells and it delivers the required genes into the Tumor cells making the required alteration in these genes.

The Therapeutic genes when hitches on to the T cells the genes are not detected or eliminated by the immune surveillance of the host immune system due to the masking of the genes by the T cells, it avoids detection and destruction by the host immune system. The study was conducted successfully in mice using human and mouse cancer cells, the results of the study shows that there is a considerable reduction in metastasis or spread of cancer cells.

This gene therapy technique of T cell Hitchhiking has to be tested in humans for specifically targeting the tumor cell or disease condition. The concept works by T cell masking and when it reaches the tumor the viral transporter successfully transfers a gene to both mouse and human tumor cells that infects the cells. Dr Richard said, “Any clinical situation in which cells home to disease sites -- such as inflammation or autoimmune disease -- might benefit from this approach,
'"/>




Page: 1

Related medicine news :

1. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
2. Therapeutic cloning by regenerating stem cells from heart muscles
3. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
4. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
5. Clinical-trials Show Increased Therapeutic Activity of Pycnogenol than Daflon
6. Safety of Cancer Therapeutic Viruses Enhanced
7. Researchers Enhance Safety and Effectiveness of Therapeutic Virus that Fights Cancer
8. Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning
9. Contemporary Therapeutic Guidelines For HIV Patients
10. Potential New Therapeutic Target for Asthma, Allergies and Cancer
11. VBI Provides Potential Targets to Diabetes Therapeutics

Post Your Comments:
(Date:11/25/2009)...inelleMedicalInc.,aleadingmanufacturerofbreastMRIc...ofnewleadingedgeclinicalapplicationsonitsAegis(TM)...icalSocietyofNorthAmerica(RSNA)annualmeetinginChic...ionsleveragetheuniquehighqualityimagesgeneratedbyS...tipleimagingmodalitiesformulti-parametricassessmen...
(Date:11/25/2009)...--TheBayAreaAirQualityManagementDistrictisissuingt...lert forThursday,November26,2009whichbansburning...ndoorsandoutdoors. ,, "Cold,stillweatherwillcon...dbent,executiveofficeroftheAirDistrict."We,reaskin...sandfellowcommunitymembersthisThanksgiving,andnott...
(Date:11/25/2009)...t of a collaboration between UCLA engineers and ph...y 10 million Americans who suffer from peripheral ...of the arteries, peripheral arterial disease, or P...wed arteries reduce blood flow to the limbs. The c...ease, heart attack and stroke, and its progression...
(Date:11/25/2009)...d treatment clinics to resume Monday, Nov. 30 , ...25, 2009 -- Centegra Health System is continuing t... at four Centegra Primary Care (CPC) vaccination c...ed. The clinics are at CPC sites in Huntley, Woods... follows: ,   From 4:30 to 7:30 p.m. T...
(Date:11/25/2009)...SSIONSkincare ®isproudtosupportGNC,seffortsto...alSt.Jude ThanksandGiving campaign,$1fromthepurcha...LipBalm willbedonatedtoSt.Jude.Additionally,GNCcus...tcheckoutatoneoftheir5,000+retaillocationsoratGNC....ngtheir2009 ThanksandGiving campaign. ,, "Weare...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...., MARCH 17, 2009 The medical costs that business...ould cover the costs for nearly a dozen healthy, f... the March of Dimes. , The average medical cost ..., according to the new data. For premature and/or ...
... Fla., March 16 eDiets.com, Inc. (Nasdaq: DIET ...fitness and healthy lifestyle solutions, today ann...onths ended December 31, 2008. , , Revenues for t...hare, for the fourth quarter of 2008 compared to $...
...TING, Pa., March 16 /PRNewswire-Asia-FirstCall/ --...Sunstone", "we" or the "Company"),today announced ...0.0% Secured,Promissory Notes due May 1, 2009 (the...ount 10.0% senior secured, promissory notes ...
...alif., March 16 The Ensign Group, Inc. (Nasdaq: ...p of skilled nursing, rehabilitative care services...at its Board of Directors has declared a quarterly...has been a dividend-paying company since 2002. , ...
...ke tough choice on whether it,s worthwhile, expert...) -- Implanted defibrillators don,t seem to provi...t failure, a new study finds. , A defibrillator ca...gressive loss of the heart,s ability to pump blood...
...us the nation is getting fatter, and that obesity ...tory, according to one University of Houston socio...een a shift in body weight over the years, assista...n says. And the use of the Body Mass Index, which ...
Other Medicine News:Health News:Medical costs for one premature baby could cover a dozen healthy births 2Health News:Medical costs for one premature baby could cover a dozen healthy births 3Health News:eDiets.com(R) Announces Q4 2008 Results 2Health News:eDiets.com(R) Announces Q4 2008 Results 3Health News:eDiets.com(R) Announces Q4 2008 Results 4Health News:eDiets.com(R) Announces Q4 2008 Results 5Health News:eDiets.com(R) Announces Q4 2008 Results 6Health News:eDiets.com(R) Announces Q4 2008 Results 7Health News:BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009 2Health News:Defibrillator May Not Help Many With Heart Failure 2Health News:Defibrillator May Not Help Many With Heart Failure 3Health News:UH sociologist has different perspective on obesity 'epidemic' 2Health News:UH sociologist has different perspective on obesity 'epidemic' 3
(Date:11/25/2009)...ass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartW...inginnovatorandprovideroflessinvasive,miniaturized...eatmentofadvancedheartfailure,todayannouncedthatit...nualPiperJaffrayHealthCareConferenceat8:00amESTonW...theNewYorkPalaceHotel,December1-2. ,, Alivewebc...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nas...foraorticdisorders,announcedtodaythatithasfiledamo...infringementlawsuitbroughtagainstitinOctober2009by...tCourtinIndianapolis,Indiana. ,, Endologixhasre...esPatentandTrademarkOffice(USPTO)conductsproceedin...
(Date:11/24/2009)...E,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.an...nistration(FDA)hasacceptedforreviewEisai,sNewDrugA...ezilHClextendedrelease)tabletsforthetreatmentofmod...oseformulationcontains23mgofdonepezilHClinanextend...allowsforgradualreleaseofthedrug.TheNDAisbasedonah...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Prolonged Use of Pacifier Linked to Speech Problems 59896 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2
... aimed at reducing cross contamination ...E, Fla., Oct. 18 Seal Shield Corporation,announce...l products for,infection control. Notably, Seal Sh... Washable Keyboard and Mouse. According to the com...he first ever antibacterial,keyboard and mouse to ...
...ssion, ATRIPLA Would Represent the, First and Only...S Patients in the European ... WHITEHOUSE STATION, N.J., Oct.,18 Bristol-Myers ... (Nasdaq: GILD ) and Merck & Co., Inc. (NYSE: MR...al Products for Human Use,(CHMP) of the European M...
Other Medicine Technology:Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 2Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10
USA Elite System™ Visual Urethrotome
USA Elite System™ Visual Urethrotome Kit
Classic Series™ Otis Urethrotome
...-2000 Flexible Cystoscope with Slide-On EndoSheath...ue and efficient solution for Urologists in both t...conventional flexible cystoscopes, which require r...-2000 eliminates the need to reprocess between eve...
Medicine Products: